MedTrace Logo

The RESPOND Outcomes Study

NCT04090151 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 37853

Last updated 2024-04-12

No results posted yet for this study

Summary

The RESPOND Outcomes study is a research study around use of antiretroviral and other relevant drugs and long-term clinical outcomes in patients living with HIV. Data collected in this study will be used to answer key unanswered questions regarding treatment of people living with HIV.

Conditions

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • ViiV Healthcare

    collaborator INDUSTRY

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Australia
  • Austria
  • Belgium
  • Denmark
  • France
  • Georgia
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04090151 on ClinicalTrials.gov